MetaCap

Recursion Pharmaceuticals Insider Trades

NASDAQ: RXRXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

4.36+0.41 (+10.38%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

After hours: 4.36 0.00%

Last 12 months

Purchases
0 · $0
Sales
18 · $2.02M
Shares bought / sold
0 / 559.35K
Net activity
Net selling $2.0 million

Recursion Pharmaceuticals insider activity

Over the last 12 months, Recursion Pharmaceuticals insiders reported 49 transactions on SEC Form 4: 0 open-market purchases and 18 sales. Insiders bought $0 and sold $2.0 million worth of stock, for net insider selling of $2.0 million. The largest seller was Borgeson Blake, with $907,200 in reported sales.

The most recent filing shows Borgeson Blake (Director) selling 50,000 shares at $4.84 on Oct 6, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put RXRX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

RXRX insider transactions

Recursion Pharmaceuticals insider transactions
DateInsiderTypeSharesValueFiling
Oct 6, 2026HERSHBERG ROBERTDirectorSale25,000$125.00KForm 4
Oct 6, 2026HERSHBERG ROBERTDirectorOption exercise25,000$55.50KForm 4
Oct 6, 2026Borgeson BlakeDirectorSale50,000$242.00KForm 4
Oct 1, 2026Li Dean YDirectorAward3,378—Form 4
Oct 1, 2026Dar ZavainDirectorAward4,607—Form 4
Sep 15, 2026Taylor Ben RChief Financial OfficerTax withholding5,396$18.40KForm 4
Sep 8, 2026Khan NajatCEO and PresidentSale22,408$78.82KForm 4
Sep 1, 2026Borgeson BlakeDirectorSale30,000$100.20KForm 4
Aug 17, 2026Taylor Ben RChief Financial OfficerTax withholding25,018$79.06KForm 4
Aug 17, 2026Hallett DavidChief Scientific OfficerTax withholding26,657$84.24KForm 4
Aug 17, 2026Khan NajatCEO and PresidentTax withholding80,498$254.37KForm 4
Aug 4, 2026Borgeson BlakeDirectorSale30,000$97.50KForm 4
Jul 7, 2026Borgeson BlakeDirectorSale40,000$158.50KForm 4
Jul 1, 2026Li Dean YDirectorAward3,747—Form 4
Jul 1, 2026Dar ZavainDirectorAward5,109—Form 4
Jun 18, 2026Bumpus NamandjeDirectorSale3,963$12.60KForm 4
Jun 17, 2026Li Dean YDirectorAward88,424—Form 4
Jun 17, 2026Bumpus NamandjeDirectorAward88,424—Form 4
Jun 17, 2026Dar ZavainDirectorAward88,424—Form 4
Jun 17, 2026Michor FranziskaDirectorAward88,424—Form 4
Jun 17, 2026Sun Elaine DDirectorAward88,424—Form 4
Jun 17, 2026HERSHBERG ROBERTDirectorAward88,424—Form 4
Jun 17, 2026Borgeson BlakeDirectorAward88,424—Form 4
Jun 15, 2026Taylor Ben RChief Financial OfficerTax withholding5,396$17.00KForm 4
Jun 5, 2026Khan NajatCEO and PresidentSale23,588$84.46KForm 4
Jun 5, 2026Gibson ChristopherDirectorSale40,000$144.80KForm 4
Jun 5, 2026Gibson ChristopherDirectorConversion40,000—Form 4
Jun 3, 2026Bumpus NamandjeDirectorSale4,386$15.53KForm 4
Jun 2, 2026Borgeson BlakeDirectorSale30,000$110.40KForm 4
May 22, 2026Gibson ChristopherDirectorSale40,000$123.20KForm 4
May 22, 2026Gibson ChristopherDirectorConversion40,000—Form 4
May 15, 2026Taylor Ben RChief Financial OfficerTax withholding25,018$76.05KForm 4
May 15, 2026Gibson ChristopherDirectorTax withholding22,821$69.38KForm 4
May 15, 2026Khan NajatCEO and PresidentTax withholding62,701$190.61KForm 4
May 15, 2026Hallett DavidChief Scientific OfficerTax withholding26,657$81.04KForm 4
May 7, 2026Gibson ChristopherDirectorGift20,000—Form 4
May 7, 2026Gibson ChristopherDirectorSale40,000$134.80KForm 4
May 7, 2026Gibson ChristopherDirectorConversion60,000—Form 4
May 5, 2026Borgeson BlakeDirectorSale30,000$105.60KForm 4
Apr 22, 2026Gibson ChristopherDirectorSale40,000$144.40KForm 4
Apr 22, 2026Gibson ChristopherDirectorConversion40,000—Form 4
Apr 7, 2026Borgeson BlakeDirectorSale30,000$93.00KForm 4
Apr 7, 2026Gibson ChristopherDirectorSale40,000$124.00KForm 4
Apr 7, 2026Gibson ChristopherDirectorConversion40,000—Form 4
Apr 6, 2026Taylor Ben RChief Financial OfficerTax withholding48,028$149.37KForm 4
Apr 1, 2026Dar ZavainDirectorAward4,902—Form 4
Apr 1, 2026Li Dean YDirectorAward3,268—Form 4
Mar 23, 2026Gibson ChristopherDirectorSale40,000$130.00KForm 4
Mar 23, 2026Gibson ChristopherDirectorConversion40,000—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related